BIOMAT Database Logo BIOMAT Database Logo

Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. 1972

L S Krain, and J W Landau, and V D Newcomer

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D002386 Cataract Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed) Cataract, Membranous,Lens Opacities,Pseudoaphakia,Cataracts,Cataracts, Membranous,Lens Opacity,Membranous Cataract,Membranous Cataracts,Opacities, Lens,Opacity, Lens,Pseudoaphakias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

L S Krain, and J W Landau, and V D Newcomer
Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.
August 1974, Canadian Medical Association journal,
L S Krain, and J W Landau, and V D Newcomer
Bullous pemphigoid and pemphigus vulgaris.
June 2017, BMJ (Clinical research ed.),
L S Krain, and J W Landau, and V D Newcomer
Bullous pemphigoid and pemphigus vulgaris.
March 1983, Annals of allergy,
L S Krain, and J W Landau, and V D Newcomer
Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid.
May 1997, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
L S Krain, and J W Landau, and V D Newcomer
Incidence of bullous pemphigoid and pemphigus vulgaris.
July 2008, BMJ (Clinical research ed.),
L S Krain, and J W Landau, and V D Newcomer
Bullous pemphigoid complicated with pemphigus vulgaris?
January 1994, Dermatology (Basel, Switzerland),
L S Krain, and J W Landau, and V D Newcomer
Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment.
July 2020, Dermatology practical & conceptual,
L S Krain, and J W Landau, and V D Newcomer
Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
February 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
L S Krain, and J W Landau, and V D Newcomer
Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
January 1983, Clinical immunology reviews,
L S Krain, and J W Landau, and V D Newcomer
[Immunosuppressive therapy of pemphigus vulgaris and bullous pemphigoid].
January 1970, Archiv fur klinische und experimentelle Dermatologie,
Copied contents to your clipboard!